Gene · 3799
Papers2,390
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
521 to 540 of 2,390
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A case of ALK-positive histiocytosis with multiple lesions in the unilateral breast: A case report. | Int J Surg Case Rep | 2022 | 35908452 | PubTator, text mining | PubMed |
| Unbiased proteomic analysis of extracellular vesicles secreted by senescent human vascular smooth muscle cells reveals their ability to modulate immune cell functions. | Geroscience | 2022 | 35900662 | PubTator, text mining | PubMed |
| Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer. | Diagnostics (Basel) | 2022 | 35892510 | PubTator, text mining | PubMed |
| Gene Expression Characteristics of Tumor and Adjacent Non-Tumor Tissues of Pancreatic Ductal Adenocarcinoma (PDAC) In-Silico. | Iran J Biotechnol | 2022 | 35891953 | PubTator, text mining | PubMed |
RNA Sequencing Reveals the Expression Profiles of circRNAs and Indicates Hsa_circ_0070562 as a Pro-osteogenic Factor in Bone Marrow-Derived Mesenchymal Stem Cells of Patients With Ankylosing Spondylitis. | Front Genet | 2022 | 35873481 | PubTator, text mining | PubMed |
| Landscape of somatic alterations in large-scale solid tumors from an Asian population. | Nat Commun | 2022 | 35871175 | PubTator, text mining | PubMed |
| The evolution of synaptic and cognitive capacity: Insights from the nervous system transcriptome of Aplysia. | Proc Natl Acad Sci U S A | 2022 | 35867761 | PubTator, text mining | PubMed |
| Kinesin-8-specific loop-2 controls the dual activities of the motor domain according to tubulin protofilament shape. | Nat Commun | 2022 | 35859148 | PubTator, text mining | PubMed |
| Identification and therapeutic evaluation of ALK rearrangements in non-small-cell lung cancer. | J Pathol Clin Res | 2022 | 35848751 | PubTator, text mining | PubMed |
| CircKIF5B Promotes Hepatocellular Carcinoma Progression by Regulating the miR-192 Family/XIAP Axis. | Front Oncol | 2022 | 35847962 | PubTator, text mining | PubMed |
| Primary pulmonary epithelioid inflammatory myofibroblastic sarcoma: a rare entity and a literature review. | J Pathol Transl Med | 2022 | 35843628 | PubTator, text mining | PubMed |
| Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery. | Nat Commun | 2022 | 35831314 | PubTator, text mining | PubMed |
| JIP3 interacts with dynein and kinesin-1 to regulate bidirectional organelle transport. | J Cell Biol | 2022 | 35829703 | PubTator, text mining | PubMed |
| Distinct proteomic profiles in prefrontal subareas of elderly major depressive disorder and bipolar disorder patients. | Transl Psychiatry | 2022 | 35821008 | PubTator, text mining | PubMed |
| The emerging landscape of EFGR tyrosine kinase inhibitors in lung adenocarcinoma-successes and challenges. | J Thorac Dis | 2022 | 35813761 | PubTator, text mining | PubMed |
| Neuroprotective and Neurotoxic Effects of Glial-Derived Exosomes. | Front Cell Neurosci | 2022 | 35813501 | PubTator, text mining | PubMed |
| KIFC3 Promotes Proliferation, Migration, and Invasion in Colorectal Cancer via PI3K/AKT/mTOR Signaling Pathway. | Front Genet | 2022 | 35812733 | PubTator, text mining | PubMed |
| Yin Yang 1 promotes aggressive cell growth in high-grade breast cancer by directly transactivating kinectin 1. | MedComm (2020) | 2022 | 35811688 | PubTator, text mining | PubMed |
| State-of-the-Art Molecular Oncology of Lung Cancer in Taiwan. | Int J Mol Sci | 2022 | 35806042 | PubTator, text mining | PubMed |
| Durable Response to Combined Osimertinib and Pralsetinib Treatment for Osimertinib Resistance Due to Novel Intergenic ANK3-RET Fusion in EGFR-Mutated Non-Small-Cell Lung Cancer. | JCO Precis Oncol | 2022 | 35797511 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3799/papers?page=27